Patent details
EP2989114 Title: 2,2-DIFLUOROPROPIONAMIDE DERIVATIVES OF BARDOXOLONE METHYL, POLYMORPHIC FORMS AND METHODS OF USE THEREOF
Basic Information
- Publication number:
- EP2989114
- PCT Application Number:
- US2014035279
- Type:
- European Patent Granted for LU
- Legal Status:
- In force
- Application number:
- EP147273064
- PCT Publication Number:
- WO2014176415
- First applicant's nationality:
- Translation Language:
- EPO Publication Language:
- English
- English Title of Invention:
- 2,2-DIFLUOROPROPIONAMIDE DERIVATIVES OF BARDOXOLONE METHYL, POLYMORPHIC FORMS AND METHODS OF USE THEREOF
- French Title of Invention:
- DÉRIVÉS 2,2-DIFLUOROPROPIONAMIDE DE BARDOXOLONE MÉTHYLE, FORMES POLYMORPHES ET PROCÉDÉS D'UTILISATION
- German Title of Invention:
- 2,2-DIFLUORPROPIONAMIDDERIVATE VON BARDOXOLONMETHYL, POLYMORPHE FORMEN DAVON UND VERFAHREN ZUR VERWENDUNG DAVON
- SPC Number:
Dates
- Filing date:
- 24/04/2014
- Grant date:
- 23/05/2018
- EP Publication Date:
- 02/03/2016
- PCT Publication Date:
- 30/10/2014
- Claims Translation Received Date:
- Translations Received Date (B1 EP Publication):
- Translations Received Date (B2 EP Publication):
- Translations Received Date (B3 EP Publication):
- Publication date:
- 23/05/2018
- EP B1 Publication Date:
- 23/05/2018
- EP B2 Publication Date:
- EP B3 Publication Date:
- Lapsed date:
- Expiration date:
- 24/04/2034
- Renunciation date:
- Revocation date:
- Annulment date:
Owner
- From:
- 07/12/2023
- Name:
- REATA PHARMACEUTICALS HOLDINGS, LLC
- Address:
- 5320 Legacy Drive, Plano, 75024, Texas, Texas, United States (US)
History of Owners
- From:
- 16/05/2018
- To:
- 07/12/2023
- Name:
- AbbVie Inc.
- Address:
- 1 North Waukegan Road, North Chicago, IL 60064, United States (US)
Agent
- Name:
- Office FREYLINGER S.A.
- From:
- 30/05/2018
- Address:
- PO Box 48, 8001, STRASSEN, Luxembourg (LU)
- To:
Inventor
1
- Name:
- SHEIKH, Ahmad Y.
- Address:
- United States (US)
2
- Name:
- WANG, Xiu C.
- Address:
- United States (US)
3
- Name:
- MATTEI, Alessandra
- Address:
- United States (US)
Priority
- Priority Number:
- 201361815502 P
- Priority Date:
- 24/04/2013
- Priority Country:
- United States (US)
Classification
- IPC classification:
- A61K 31/565; A61P 29/00; C07J 63/00;
Publication
Bulletin
- Bulletin Heading:
- CO
- Bulletin edition number:
- 2024/01
- Publication date:
- 05/01/2024
- Description:
- Section M : Transfers of property (Art. 53 of the law), change of name and/or address
European Patent Bulletin
1
- Issue number:
- 201821
- Publication date:
- 23/05/2018
- Description:
- Grant (B1)
2
- Issue number:
- 201824
- Publication date:
- 13/06/2018
- Description:
- Application number/publication number of the divisional application (Art. 76) changed
Deed
Change of owner(s)
- Change Kind/ Decision Type:
- Change of ownership
- Deed Number:
- RC20230000513A
- Date Registered:
- 07/12/2023
- Licence Effective Date:
- Licence Expiration Date:
- Scope of Licence:
- Deed Filer:
- OFFICE FREYLINGER S.A.
- Journal Edition Number:
- Text:
- Country Code:
- Updated Licence Number:
- Terminated Licence Number:
Added Owner(s)
- Name:
- REATA PHARMACEUTICALS HOLDINGS, LLC
- Address:
- 5320 Legacy Drive, Plano, 75024, Texas, United States (US)
Removed Pledgee
- Name:
- Address:
Annual Fees
- Annual Fee Due Date:
- 30/04/2027
- Annual Fee Number:
- 14
- Annual Fee Amount:
- 198 Euro
- Expected Payer:
- Last Annual Fee Payment Date:
- 19/03/2026
- Last Annual Fee Paid Number:
- 13
- Last Annual Fee Paid Amount:
- 180 Euro
- Payer:
- ANAQUA SERVICES (ANC. SGA2)
| Filing date | Document type | Number of pages |
|---|---|---|
| 07/12/2023 | Request For Change | 15 |
| 08/12/2023 | Outgoing Correspondence | 1 |
| 11/06/2018 | Outgoing Correspondence | 1 |
| 30/05/2018 | Power Of Attorney | 1 |